tirzepatide and bone density GLP-1s loss! | Dr Karan GLP-1 Agonists and Orthopedic Surgery:

[DOI] [PubMed] [Google Scholar] 15.Gaede P, Vedel P, Larsen N, et al

Metabolic/Bariatric Surgery (Third-Line) Indicated for BMI 40 or BMI 35 with obesity-related comorbidities (DM2, HTN, OSA, OA)

Despite advancements in managing HS, effective treatments remain limited and can cause serious side effects, highlighting a need for alternative and better-tolerated treatment options.

The quadrivalent HPV vaccine has not been in use in the United States since May 1, 2017

According to a release by the Center for Medicare and Medicade Services, the program runs through December 31, 2027, and is designed to bridge the gap while a longer-term coverage plan is worked out